<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-140273" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Congenital Hypertrophy of Retinal Pigment Epithelium</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ireland</surname>
            <given-names>Ashley C.</given-names>
          </name>
          <aff>CorrectVision Laser Institute</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rodman</surname>
            <given-names>Julie</given-names>
          </name>
          <aff>New England College of Optometry, Boston, MA</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ashley Ireland declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Julie Rodman declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>15</day>
          <month>5</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-140273.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Congenital hypertrophy of the retinal pigmented epithelium (CHRPE) is a benign ocular condition characterized by well-defined, flat, pigmented lesions primarily located in the fundus of the eye.&#x000a0;CHRPE lesions are typically unilateral and solitary, although multiple or bilateral occurrences are possible, and they are often asymptomatic, usually discovered incidentally during routine eye examinations.&#x000a0;While generally benign, CHRPE lesions may exhibit subtle changes over time, such as slight enlargement or alterations in pigmentation.&#x000a0;Although CHRPE lesions typically do not cause visual disturbances, further evaluation may be warranted to rule out related syndromes or differential diagnoses, especially in cases of multiple or atypical lesions.&#x000a0;</p>
        <p>Management involves periodic monitoring to detect changes in size or morphology, with intervention reserved for cases with concerning features or associated pathology.&#x000a0;A thorough systemic evaluation is recommended in cases of atypical or multiple CHRPEs to exclude related syndromes such as familial adenomatous polyposis. Treatment is generally unnecessary for solitary CHRPE and grouped retina pigmentation, with observation being the primary approach. In cases associated with syndromes such as familial adenomatous polyposis, collaboration with other specialists may be necessary, and regular follow-up and patient education are crucial. In addition, routine endoscopies and genetic screening are recommended in some cases.&#x000a0;This activity aims to enhance the competence of healthcare professionals in identifying CHRPE, conducting the recommended evaluation, and implementing an appropriate interprofessional approach for managing this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify congenital hypertrophy of the retinal pigmented epithelium&#x000a0;lesions accurately during routine eye examinations.</p></list-item><list-item><p>Implement periodic monitoring protocols to detect changes in the size or morphology of congenital hypertrophy of the retinal pigmented epithelium.</p></list-item><list-item><p>Apply appropriate imaging modalities to precisely diagnose and monitor the progression of&#x000a0;congenital hypertrophy of the retinal pigmented epithelium.</p></list-item><list-item><p>Collaborate with other interprofessional healthcare specialists to comprehensively evaluate and manage syndromes related to congenital hypertrophy of the retinal pigmented epithelium.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=140273&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=140273">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-140273.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Congenital hypertrophy of the retinal pigmented epithelium (CHRPE) is a benign ocular condition characterized&#x000a0;by well-defined, flat, pigmented lesions primarily located in the fundus of the eye.<xref ref-type="bibr" rid="article-140273.r1">[1]</xref> CHRPE lesions are typically unilateral and solitary, although multiple or bilateral occurrences have been reported.<xref ref-type="bibr" rid="article-140273.r2">[2]</xref>&#x000a0;These lesions are usually discovered incidentally during routine ophthalmic examinations, often in asymptomatic individuals.<xref ref-type="bibr" rid="article-140273.r2">[2]</xref>&#x000a0;Fundoscopic examination may reveal solitary CHRPE lesions, which are more common, grouped lesions, or atypical multiple CHRPE lesions, often associated with disorders such as familial adenomatous polyposis (FAP) syndrome, Gardner syndrome, and Turcot syndrome.<xref ref-type="bibr" rid="article-140273.r3">[3]</xref><xref ref-type="bibr" rid="article-140273.r4">[4]</xref>&#x000a0;</p>
        <p>While generally considered benign, CHRPE lesions may occasionally undergo malignant transformation.<xref ref-type="bibr" rid="article-140273.r5">[5]</xref><xref ref-type="bibr" rid="article-140273.r6">[6]</xref>&#x000a0;Thus, patients diagnosed with CHRPE should undergo a thorough systemic evaluation to exclude associated syndromes.<xref ref-type="bibr" rid="article-140273.r7">[7]</xref><xref ref-type="bibr" rid="article-140273.r8">[8]</xref> The management of isolated CHRPE lesions typically involves regular monitoring with ophthalmic examinations to detect any changes suggestive of malignant transformation or growth.<xref ref-type="bibr" rid="article-140273.r9">[9]</xref> In cases where CHRPE lesions are associated with FAP syndrome, a multidisciplinary approach involving collaboration with gastroenterologists for colorectal cancer screening and genetic counseling is warranted.<xref ref-type="bibr" rid="article-140273.r10">[10]</xref><xref ref-type="bibr" rid="article-140273.r11">[11]</xref><xref ref-type="bibr" rid="article-140273.r12">[12]</xref> While CHRPE lesions do not usually require treatment, patient education regarding the potential risk of malignant transformation and regular follow-up is essential.</p>
      </sec>
      <sec id="article-140273.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>CHRPE is a term commonly used to describe&#x000a0;conditions that exhibit similar clinical features but vary significantly in etiology, prognosis, and management. Various studies have proposed the CHRPE names and abbreviations below to accurately describe and differentiate between these conditions.</p>
        <p><bold>Typical or solitary</bold>: This type of CHRPE&#x000a0;is generally characterized by unilateral and solitary lesions not associated with systemic&#x000a0;conditions. These lesions develop sporadically and are almost always benign. Typical CHRPEs are often regarded as the only true CHRPEs.<xref ref-type="bibr" rid="article-140273.r13">[13]</xref></p>
        <p><bold>Grouped or multifocal</bold>: These lesions&#x000a0;are&#x000a0;usually unilateral and appear similar to CHRPE but are multifocal. Grouped CHRPE lesions are clustered within a quadrant of the retina, often referred to as "bear tracks." They are congenital and benign, with no associated systemic conditions.<xref ref-type="bibr" rid="article-140273.r14">[14]</xref></p>
        <p><bold>Pigmented ocular fundus lesions of familial adenomatous</bold>
<bold>polyposis</bold>:&#x000a0;Also referred to as multiple CHRPEs or atypical CHRPEs, pigmented ocular fundus lesions of FAP (PO-FLs)&#x000a0;are multifocal, similar to grouped CHRPEs.<xref ref-type="bibr" rid="article-140273.r15">[15]</xref>&#x000a0;However, these lesions are typically&#x000a0;bilateral. Unlike other CHRPE variants, PO-FLs are associated with a group of hereditary&#x000a0;genetic colonic polyposis conditions.<xref ref-type="bibr" rid="article-140273.r16">[16]</xref>&#x000a0;The location of the adenomatous polyposis coli (APC) gene mutation may influence the expression of PO-FLs.<xref ref-type="bibr" rid="article-140273.r17">[17]</xref></p>
        <p>FAP is an autosomal dominant inherited condition resulting from a mutation in the APC tumor suppressor gene (chromosome 5q21&#x02013;q22).<xref ref-type="bibr" rid="article-140273.r16">[16]</xref>&#x000a0;Severe FAP, characterized by more than 1000 colorectal adenomas, is associated with <italic toggle="yes">APC</italic> mutations between codons 1250 and 1464.<xref ref-type="bibr" rid="article-140273.r18">[18]</xref>&#x000a0;Attenuated FAP, with fewer than 100 colorectal adenomas, is attributed to mutations before codon 157, in the spliced region of exon 9, and mutations after 1595. All other mutations lead to intermediate FAP.<xref ref-type="bibr" rid="article-140273.r18">[18]</xref><xref ref-type="bibr" rid="article-140273.r19">[19]</xref>&#x000a0;Mutations between codon 446 and codon 1338 are associated with multiple CHRPE lesions, while mutations between codons 1445 and 1578 are not.<xref ref-type="bibr" rid="article-140273.r20">[20]</xref></p>
        <p>FAP is characterized by the&#x000a0;development of hundreds of polyps within the colon&#x000a0;that&#x000a0;progress to colorectal cancer in nearly all untreated patients.<xref ref-type="bibr" rid="article-140273.r21">[21]</xref><xref ref-type="bibr" rid="article-140273.r8">[8]</xref>&#x000a0;FAP often presents with extracolonic manifestations, including CHRPE-like lesions in the retina.<xref ref-type="bibr" rid="article-140273.r14">[14]</xref>&#x000a0;Gardner syndrome and Turcot syndrome are variants of FAP that are also associated with the development of PO-FLs.<xref ref-type="bibr" rid="article-140273.r22">[22]</xref> Due to the potentially dire prognosis of this condition, eye care clinicians must be able to distinguish PO-FLs from their benign counterparts.<xref ref-type="bibr" rid="article-140273.r23">[23]</xref></p>
      </sec>
      <sec id="article-140273.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Prevalence rates of typical CHRPE&#x000a0;have not been well defined in the literature and show significant variability between studies, ranging from 0.4% to 30%.<xref ref-type="bibr" rid="article-140273.r24">[24]</xref>&#x000a0;Coleman et al found a prevalence rate of 1.20% among a group of&#x000a0;1745 study subjects, subjects, with only 2 of these subjects presenting with multifocal lesions, accounting for a prevalence of less than 1%, and both lesions were unilateral in presentation.<xref ref-type="bibr" rid="article-140273.r13">[13]</xref>&#x000a0;Numerous studies have found no sexual preference for typical CHRPE lesions.<xref ref-type="bibr" rid="article-140273.r13">[13]</xref>&#x000a0;</p>
        <p>Mirinezhad et al noted the presence of CHRPE in 78% of patients with FAP and 38% of their siblings.<xref ref-type="bibr" rid="article-140273.r25">[25]</xref>&#x000a0;Multiple CHRPEs may be found in up to 90% of patients with FAP.<xref ref-type="bibr" rid="article-140273.r26">[26]</xref><xref ref-type="bibr" rid="article-140273.r8">[8]</xref>&#x000a0;FAP has a prevalence of approximately 1 in 8300 to 1 in 37,600 individuals.<xref ref-type="bibr" rid="article-140273.r27">[27]</xref>&#x000a0;On average, FAP occurs in 1 in 10,000 individuals.<xref ref-type="bibr" rid="article-140273.r21">[21]</xref>&#x000a0;In a systematic literature review, the mean specificity of CHRPE as a phenotypic marker of FAP was 89%, with a sensitivity of 79%.<xref ref-type="bibr" rid="article-140273.r8">[8]</xref></p>
      </sec>
      <sec id="article-140273.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Specific histological changes in retinal pigment epithelial (RPE) cells and disruptions of retinal homeostasis underlie the development of retinal and CHRPE lesions.<xref ref-type="bibr" rid="article-140273.r1">[1]</xref>&#x000a0;Solitary and multifocal CHRPEs represent sporadic, benign abnormalities of RPE cells, also referred to as retinal hamartomas. Histopathological changes in RPE cell size, number, and content lead to cellular dysfunction and the loss of homeostasis among the RPE, choroid, and neural retina in the affected area.</p>
      </sec>
      <sec id="article-140273.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Although CHRPE refers to specific hypertrophic cellular changes, histological analysis shows various morphologic cellular changes&#x000a0;of CHRPE and its variants.&#x000a0;RPE cells in&#x000a0;typical<italic toggle="yes">&#x000a0;</italic>CHRPEs exhibit various degrees of cellular&#x000a0;hypertrophy. In hypertrophy, normal, cuboidal RPE cells are vertically elongated and columnar. Moreover, multiple studies have indicated that cells also undergo hyperplasia, leading to thickening of the RPE layer. Large melanosomes or macromelanosomes are evident in the RPE.<xref ref-type="bibr" rid="article-140273.r28">[28]</xref>&#x000a0;These round pigment granules contrast with the wedge-shaped melanin granules in normal RPE.&#x000a0;These changes disrupt the ability of the RPE to support the overlying photoreceptors, resulting in cell loss and thinning.<xref ref-type="bibr" rid="article-140273.r29">[29]</xref>&#x000a0;</p>
        <p>In the absence of photoreceptors, the production of lipofuscin, a waste product secondary to the normal RPE-mediated phagocytosis of photoreceptor outer segments, is diminished.<xref ref-type="bibr" rid="article-140273.r14">[14]</xref>&#x000a0;Atrophic areas, known as lacunae, may also develop throughout the&#x000a0;lesion and correlate with a depigmented funduscopic appearance. Compared to normal cuboidal RPE cells, affected RPE cells are&#x000a0;vertically elongated and range from cuboidal to columnar. They possess large, spherical intracytoplasmic melanin granules of much higher density than normal RPE cells. In addition, the adjacent Bruch membrane is thickened due to the thickening of the basement membrane of the RPE.<xref ref-type="bibr" rid="article-140273.r30">[30]</xref>&#x000a0;The choroid, choriocapillaris, and other layers of the Bruch membrane are normal.</p>
        <p>Conversely, grouped CHRPE has been observed to contain histologically normal cells, showing no variance in cell size or density compared to normal RPE cells.&#x000a0;Instead, its hyperpigmented appearance results from the increased density of melanin granules, which are large and ellipsoid in shape.&#x000a0;Bruch membrane is normal in these cases.<xref ref-type="bibr" rid="article-140273.r31">[31]</xref>&#x000a0;Several atypical CHRPEs exhibit histological similarities to typical lesions, featuring hypertrophic and hyperplastic RPE cells along with thickening of the adjacent Bruch membrane.<xref ref-type="bibr" rid="article-140273.r13">[13]</xref><xref ref-type="bibr" rid="article-140273.r14">[14]</xref>&#x000a0;In addition, retinal vascular changes or retinal invasion may be observed.</p>
        <p>In FAP (ie, Gardner syndrome), a generalized abnormality of melanogenesis in the RPE may be observed. The lesions associated with FAP may manifest in at least 3 distinct appearances.<xref ref-type="bibr" rid="article-140273.r32">[32]</xref>&#x000a0;The first pattern is similar to typical solitary CHRPE. The second pattern&#x000a0;resembles an RPE hamartoma with RPE hyperplasia and hypertrophy.<xref ref-type="bibr" rid="article-140273.r32">[32]</xref>&#x000a0;Minute mushroom-shaped lesions characterize the third pattern.<xref ref-type="bibr" rid="article-140273.r32">[32]</xref>&#x000a0;Some chronic lesions may penetrate the full thickness of the retina, thus classifying lesions associated with FAP as multiple RPE hamartomas related to FAP or polyposis-associated congenital hamartoma of the RPE.<xref ref-type="bibr" rid="article-140273.r1">[1]</xref></p>
      </sec>
      <sec id="article-140273.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>
<bold>Solitary or Unifocal Congenital Hypertrophy of the Retinal Pigmented Epithelium</bold>
</p>
        <p>Solitary CHRPEs are typically flat (98.5%) and highly&#x000a0;pigmented, appearing dark gray or black. However, approximately&#x000a0;1.5% of CHRPEs do not appear flat due to the presence of an intralesional nodule, which may increase with time (see <bold>Image. </bold>Congenital Hypertrophy of the Retinal Pigmented Epithelium [CHRPE]).<xref ref-type="bibr" rid="article-140273.r2">[2]</xref> The color is consistent across different racial backgrounds. In some cases, lesions may become entirely depigmented (12%).<xref ref-type="bibr" rid="article-140273.r2">[2]</xref> Usually, these lesions are round with well-defined smooth or scalloped borders. In about 52% of cases, a hypopigmented ring or "halo" surrounds the lesion. As the lesion matures, depigmented punched-out lacunae and a halo may develop, potentially involving the entire lesion (see&#x000a0;<bold>Image. </bold>CHRPE With Lacunae).</p>
        <p>Solitary CHRPEs are predominantly found in the equatorial fundus (45%), with the inferotemporal fundus being the most common location (31%).<xref ref-type="bibr" rid="article-140273.r2">[2]</xref>&#x000a0;In rare cases,&#x000a0;lesions may be peripapillary (1%) or macular in location (1%).<xref ref-type="bibr" rid="article-140273.r33">[33]</xref><xref ref-type="bibr" rid="article-140273.r2">[2]</xref>&#x000a0;Foveal involvement or choroidal neovascularization may lead to reduced visual acuity.<xref ref-type="bibr" rid="article-140273.r34">[34]</xref><xref ref-type="bibr" rid="article-140273.r35">[35]</xref>&#x000a0;In a large study on 330 patients with solitary CHRPE, the median age of presentation was 45, with an age range between 1 and 80.<xref ref-type="bibr" rid="article-140273.r2">[2]</xref>&#x000a0;This&#x000a0;study found no association between solitary CHRPE and FAP or colon cancer, although 8% of patients had a history of cancer, with breast cancer being the most common.<xref ref-type="bibr" rid="article-140273.r2">[2]</xref><xref ref-type="bibr" rid="article-140273.r33">[33]</xref>&#x000a0;Approximately half (43%) of pigmented CHRPEs present with hypopigmented areas of RPE atrophy, known as&#x000a0;lacunae, within the lesion.<xref ref-type="bibr" rid="article-140273.r2">[2]</xref>&#x000a0;On average, about 56.5% of the lesion surface is atrophic; however, the atrophy's presence, appearance, and extent vary between patients and do not change the patient's prognosis.</p>
        <p>The mean largest basal diameter of solitary CHRPE is approximately 4.7 mm (median 4.5 mm).<xref ref-type="bibr" rid="article-140273.r2">[2]</xref>&#x000a0;However, lesions can vary in size, ranging from approximately 100 &#x000b5;m (smaller) to occupying the entire ocular fundus quadrant (larger). Although lesions&#x000a0;are generally regarded as nonprogressive and stationary, numerous studies have demonstrated slow, benign flat enlargement over time in up to 83% of patients, for which the&#x000a0;percentage of area occupied by&#x000a0;lacunae within the CHRPE is an important factor.<xref ref-type="bibr" rid="article-140273.r36">[36]</xref><xref ref-type="bibr" rid="article-140273.r2">[2]</xref>&#x000a0;The median rate of flat enlargement of solitary CHRPE is around 10 &#x000b5;m/month.<xref ref-type="bibr" rid="article-140273.r2">[2]</xref> In addition, 32% of cases also show enlargement of lacunae in size or number over time.<xref ref-type="bibr" rid="article-140273.r2">[2]</xref>&#x000a0;Intraretinal focal pigmentation may be noted near the margin of solitary CHRPE. Lesions are often&#x000a0;found incidentally during a routine eye examination, and patients are rarely symptomatic. Visual field defects corresponding to the area of the lesion are possible; however, lesions are generally located peripherally and are unlikely to be noticeable.</p>
        <p>
<bold>Grouped or Multifocal Congenital Hypertrophy of the Retinal Pigmented Epithelium and Grouped Pigmentation of the Retina</bold>
</p>
        <p>Grouped pigmentation of the retina (GPR) resembles animal footprints or bear tracks. GPR appears similar to solitary CHRPE but presents unilaterally with 3 to 30 discreet lesions of various sizes (see <bold>Image. </bold>Bear Track Pigmented Lesions). These lesions are typically flat, round, or oval black spots with well-defined margins arranged in clusters. GPR lesions are generally smaller than unilateral CHRPEs, ranging from 0.1 to 0.3 mm in diameter, and confined to a single quadrant in the retina. Peripheral lesions are usually larger than posterior lesions and seem to radiate from the&#x000a0;optic disc along the lines of Blashko lines or to proceed toward the retinal periphery.<xref ref-type="bibr" rid="article-140273.r37">[37]</xref> Unlike solitary CHRPE, GPR lesions typically lack surrounding haloes and lacunae.<xref ref-type="bibr" rid="article-140273.r1">[1]</xref>&#x000a0;</p>
        <p>Usually, several groups or clusters of such lesions are present, mostly affecting&#x000a0;an&#x000a0;eye. Rarely, such lesions may appear depigmented, congenital grouped albinotic spots, also called "polar bear tracks." These grouped CHRPE lesions are also not associated with gastrointestinal malignancy. Meyer et al reported a male patient with bear tracks in the left eye and pigmentation in the left arm along Blashko lines.<xref ref-type="bibr" rid="article-140273.r38">[38]</xref>&#x000a0;They hypothesized that the mosaic pigmentation of skin and eye on the same side may be related to the common etiology of early postzygotic mutation.<xref ref-type="bibr" rid="article-140273.r38">[38]</xref>&#x000a0;The pigmentation pattern of GPR does not align with the retinal nerve fiber layer, suggesting RPE cell outgrowth and migration during embryogenesis.<xref ref-type="bibr" rid="article-140273.r37">[37]</xref></p>
        <p>
<bold>Pigmented Ocular Fundus Lesions of Familial Adenomatous Polyposis and Familial Adenomatous Polyposis&#x02013;Associated Lesions</bold>
</p>
        <p>PO-FLs, also called multiple CHRPEs or atypical CHRPEs, must be accurately differentiated from benign CHRPEs due to their association with severe systemic disease. Compared to their benign counterpart, PO-FLs are characterized by their bilateral and multifocal nature, extending across multiple quadrants. They commonly exhibit a "pisciform" (fish-shaped) appearance with irregular, depigmented borders (see <bold>Image</bold>. CHRPE Associated With FAP).<xref ref-type="bibr" rid="article-140273.r14">[14]</xref>&#x000a0;These lesions may vary in shape, including spindle, oval, comma, or fishtail, and can display different pigmentation patterns such as light gray, brown, or black. The size of PO-FLs may vary in the same eye but is usually smaller, approximately 50 to 100 &#x000b5;m, than solitary CHRPEs. They often exhibit irregularly depigmented or hypopigmented margins and surrounding areas. Notably, features such as retinal invasion, proliferation of RPE, glial cells, and capillaries, as well as depigmented halo, lacunae, RPE changes near retinal vessels, mottling, and pigmented satellite lesions may be present.&#x000a0;These lesions&#x000a0;are typically distributed in a haphazard pattern across the retina rather than in a sectorial arrangement.</p>
        <p>PO-FLs are congenital and have also been reported in preterm infants.<xref ref-type="bibr" rid="article-140273.r39">[39]</xref>&#x000a0;The presence of more than 4 widely spaced multiple CHRPEs in both eyes may suggest FAP or Gardner syndrome.<xref ref-type="bibr" rid="article-140273.r40">[40]</xref> However, the absence of atypical CHRPEs does not rule out FAP. Bonnet et al suggested specific criteria with high specificity and positive predictive value for detecting FAP in PO-FLs, including:&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Multiple lesions with a total of at least 3 lesions in 1 or both eyes</p>
          </list-item>
          <list-item>
            <p>Lesion type A or B according to Berk classification&#x000a0;<xref ref-type="bibr" rid="article-140273.r41">[41]</xref>&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Bilaterality&#x000a0;<xref ref-type="bibr" rid="article-140273.r8">[8]</xref></p>
          </list-item>
        </list>
        <p>The Berk classification of CHRPEs categorizes them into the following 4 types:</p>
        <list list-type="bullet">
          <list-item>
            <p>Type A: Pigmented oval lesions with a halo</p>
          </list-item>
          <list-item>
            <p>Type B: Pigment dots, small and round</p>
          </list-item>
          <list-item>
            <p>Type C: Large round pigmented lesion</p>
          </list-item>
          <list-item>
            <p>Type D: Large depigmented lesion or atrophic&#x000a0;lesion with or without a pigmented halo&#x000a0;<xref ref-type="bibr" rid="article-140273.r41">[41]</xref><xref ref-type="bibr" rid="article-140273.r8">[8]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-140273.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<bold>Dilated Fundus Examination</bold>
</p>
        <p>Detecting CHRPE lesions often requires evaluating the retinal periphery through dilated examination or nonmydriatic retinal imaging, as they are rarely found in the posterior pole. One or both procedures are virtually always performed as part of a comprehensive eye exam. Most biomicroscopes are equipped with a red-free filter that may aid in distinguishing between choroidal nevi and CHRPE lesions. Nevi disappears with red-free light, whereas CHRPE remains visible.<xref ref-type="bibr" rid="article-140273.r42">[42]</xref></p>
        <p>
<bold>Optical Coherence Tomography</bold>
</p>
        <p>Optical coherence tomography (OCT) reveals hyperreflectivity and thickening of the RPE, corresponding to elongated RPE cells. This thickening causes shadowing of the underlying choroid, with resultant retinal thinning and photoreceptor layer loss over the lesion.<xref ref-type="bibr" rid="article-140273.r43">[43]</xref>&#x000a0;Francis et al found evidence of associated choroidal atrophy when lesions were imaged with spectral domain OCT (SD-OCT). They found that the inner layers of the choroid (ie, the choriocapillaris and Sattler layer) were atrophied in 97% of their cohort. Larger lesions were more likely to involve the outer choroid (Haller's layer), as noted in 53% of patients.<xref ref-type="bibr" rid="article-140273.r44">[44]</xref> Lacunae exhibit RPE loss and increased light transmission, potentially affecting visual function. Visual field loss or microperimetry changes may be attributed to photoreceptor atrophy, with subretinal clefts observed in certain cases.</p>
        <p>
<bold>Fluorescein Angiography</bold>
</p>
        <p>Fluorescein angiography reveals hypofluorescence of lesions due to the "block effect," caused by hypertrophic RPE cells anterior to the choroidal vasculature, obstructing the visualization of normal background fluorescein leakage. If present, lacunae within lesions will appear hyperfluorescent.<xref ref-type="bibr" rid="article-140273.r45">[45]</xref>&#x000a0;In some cases, changes in retinal vasculature may occur, which can be detected with fluorescein angiography, including capillary nonperfusion areas, neovascularization, capillary microaneurysms, dye leakage, and chorioretinal anastomosis. Polar bear tracks show early and late hyperfluorescence consistent with window defects.<xref ref-type="bibr" rid="article-140273.r46">[46]</xref></p>
        <p>
<bold>Indocyanine Green Angiogram</bold>
</p>
        <p>Indocyanine green angiography similarly depicts blocked fluorescence within the region of pigmented lesions, although choroidal vessels may be visible through the lacunae.</p>
        <p>
<bold>Fundus Autofluorescence</bold>
</p>
        <p>Fundus autofluorescence imaging typically reveals lesions as strongly hypoautofluorescent, although lacunae may exhibit slight hyperautofluorescence due to their melanin-rich composition and limited presence of lipofuscin.<xref ref-type="bibr" rid="article-140273.r47">[47]</xref>&#x000a0;Polar bear tracks also show hypoautofluorescence, possibly due to RPE atrophy.<xref ref-type="bibr" rid="article-140273.r46">[46]</xref>&#x000a0;An alternate theory suggests the absorption or blockage of normal autofluorescence by abnormal melanin precursor material.<xref ref-type="bibr" rid="article-140273.r46">[46]</xref>&#x000a0;</p>
        <p>
<bold>B-Scan Ultrasonography</bold>
</p>
        <p>B-scan ultrasonography is not typically diagnostic for CHRPE but can assist in measuring the thickness of the lesion.&#x000a0;Ultrasound A or B scan may not detect or document these lesions, as these lesions are flat.<xref ref-type="bibr" rid="article-140273.r1">[1]</xref></p>
        <p>
<bold>Visual Field Analysis</bold>
</p>
        <p>Although patients can manifest a visual field defect corresponding to the area of the CHRPE, they are unlikely to be detected through visual field analysis. This is because most lesions are situated more peripherally than the testing area covered by Humphrey visual field analyzers. The depth of the defect (absolute versus relative) usually correlates with lesion size. However, some studies suggest that younger patients typically manifest relative visual field defects, while older patients manifest absolute defects.<xref ref-type="bibr" rid="article-140273.r43">[43]</xref></p>
        <p><bold>Optical Coherence Tomography Angiogram</bold>In solitary CHRPE cases, OCT angiography typically shows normal retinal vasculature, although interpretation can be challenging due to segmentation artifacts caused by retinal thinning.<xref ref-type="bibr" rid="article-140273.r48">[48]</xref>&#x000a0;The pigmented lesion largely blocks the choroidal vasculature. En-face OCT provides a clearer analysis of the normal choroidal vasculature in these cases.<xref ref-type="bibr" rid="article-140273.r48">[48]</xref></p>
        <p>
<bold>Electrophysiology</bold>
</p>
        <p>In eyes with CHRPE, electroretinography and electro-oculography typically yield normal results.<xref ref-type="bibr" rid="article-140273.r49">[49]</xref></p>
        <p>
<bold>Systemic Evaluation</bold>
</p>
        <p>Systemic evaluation and genetic counseling should be conducted in patients with atypical multiple CHRPEs to exclude mutations in the APC gene and APC-associated polyposis conditions, including FAP, Gardner syndrome, and Turcot syndrome.<xref ref-type="bibr" rid="article-140273.r22">[22]</xref></p>
        <p>FAP is an autosomal dominant disorder caused by a germline mutation in the <italic toggle="yes">APC</italic> gene, typically leading to the development of colon carcinoma in patients by age 50. Adenomatous polyps in the colon and rectum usually emerge during adolescence, necessitating regular colonoscopies with or without polyp excision. Atypical multiple CHRPE lesions are prevalent in 70% to 90% of FAP patients.<xref ref-type="bibr" rid="article-140273.r13">[13]</xref> Some atypical CHRPE cases manifest lesions from birth, highlighting the importance of meticulous screening, genetic testing, and regular examination for all family members due to autosomal dominant inheritance.&#x000a0;</p>
        <p>Gardner syndrome is a condition characterized by FAP along with soft tissue tumors, including lipoma, fibroma, and epidermoid cysts, as well as osteomas of the mandible, skull, and long bone. Turcot syndrome, an autosomal recessive condition, presents with brain tumors such as medulloblastoma and gliomas in association with FAP.&#x000a0;</p>
      </sec>
      <sec id="article-140273.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Solitary CHRPE and GPR do not require treatment and can be monitored periodically. Solitary lesions should undergo close examination to detect rare nodule development and associated complications or malignant transformation (Please refer to the <bold>Prognosis</bold> section for more information). The lesion's dimensions can be measured, and fundus photography can be utilized to monitor changes in size and characteristics.&#x000a0;</p>
        <p>Patients with PO-FLs should undergo routine endoscopies with their gastroenterologist to assess the presence of polyps within the colon and rectum. Genetic screening should be conducted in patients with a family history of adenomatous polyposis syndrome or patients with 10 or more polyps, regardless of family history.<xref ref-type="bibr" rid="article-140273.r50">[50]</xref>&#x000a0;The specific mutation identified through genetic testing guides the recommended frequency of screening and prognosis. However, solitary or multifocal CHRPEs are not associated with an increased risk of systemic disease and do not require further testing or referral.<xref ref-type="bibr" rid="article-140273.r14">[14]</xref></p>
      </sec>
      <sec id="article-140273.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differential diagnoses of CHRPE include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Choroidal nevus: Margins are not well defined, lesions lack the deep black appearance of CHRPE, and lacunae are absent. Overlying drusen may be observed.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Choroidal melanoma: Lesions are often elevated, with margins less sharp compared to CHRPE.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Melanocytoma of the optic nerve head: This condition typically presents with a feathery and elevated appearance.&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Congenital simple RPE hamartoma: Usually located in the posterior pole, with the margin often discernible with the lesion at the retina's inner surface on OCT.<xref ref-type="bibr" rid="article-140273.r51">[51]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Combined&#x000a0;hamartoma of the retina and RPE:&#x000a0;Typically observed in young patients with an epiretinal membrane or vitreomacular traction and pigmentary changes. OCT macula may exhibit a characteristic "omega sign."<xref ref-type="bibr" rid="article-140273.r52">[52]</xref><xref ref-type="bibr" rid="article-140273.r53">[53]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Acquired RPE hyperplasia.<xref ref-type="bibr" rid="article-140273.r13">[13]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Focal pigmentation.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Black sunburst related to sickle cell retinopathy.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Healed choroiditis or chorioretinitis.<xref ref-type="bibr" rid="article-140273.r54">[54]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Torpedo maculopathy: Characterized by a torpedo-like appearance, typically located temporal to the fovea.<xref ref-type="bibr" rid="article-140273.r55">[55]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Paving stone degeneration: Usually present in the extreme retinal periphery near the ora, commonly as multiple lesions noted in inferior or inferotemporal areas.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-140273.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Virtually all patients with solitary CHRPE or GPR are asymptomatic, and the lesions are benign. They are not associated with an increased risk of systemic disease. The prognosis is excellent. However, PO-FLs are associated with FAP, which can be fatal due to colon cancer. Therefore, regular ocular follow-ups and colonoscopies are necessary for prompt detection and management of colon polyps or cancer.</p>
      </sec>
      <sec id="article-140273.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Complications associated with CHRPE are exceedingly rare and are generally secondary to nodular growth within the lesion. Subretinal fluid or exudation from nodules may lead to retinal detachment, characterized by the separation of the RPE from the neural retina. In addition, nodules may cause secondary vitreomacular traction and decreased central vision.<xref ref-type="bibr" rid="article-140273.r1">[1]</xref>&#x000a0;Although rare (2%), evidence&#x000a0;of benign (adenoma) or malignant (adenocarcinoma) nodular transformation of RPE cells within&#x000a0;solitary&#x000a0;CHRPE lesions has been reported.<xref ref-type="bibr" rid="article-140273.r56">[56]</xref><xref ref-type="bibr" rid="article-140273.r36">[36]</xref> These transformations typically originate from the CHRPE as small pigmented nodules that grow slowly, eventually invading the sensory retina and generating their vasculature.</p>
        <p>Feeder and drainage vessels carry lipoproteinaceous material to and from the lesion. Nodules may remain stable or progress to a large pedunculated lesion, potentially causing extensive intraocular inflammation, subretinal exudation, retinal detachment, and severe vision loss.<xref ref-type="bibr" rid="article-140273.r36">[36]</xref>&#x000a0;Consequently, long-term follow-up of all CHRPE lesions is necessary. Exudative maculopathy associated with presumed RPE adenoma related to CHRPE may respond to multiple intravitreal anti-vascular endothelial growth factor agents, such as bevacizumab.<xref ref-type="bibr" rid="article-140273.r57">[57]</xref>&#x000a0;Proton beam radiotherapy represents another option for managing RPE adenocarcinoma arising from CHRPE.<xref ref-type="bibr" rid="article-140273.r58">[58]</xref> Additional complications include vitreous traction, cataracts, and posterior synechiae. However, uncomplicated cases are often monitored, as incidences of metastasis have not been reported.<xref ref-type="bibr" rid="article-140273.r36">[36]</xref>&#x000a0;Solitary CHRPE is not associated with an increased risk of gastrointestinal malignancy.</p>
      </sec>
      <sec id="article-140273.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should receive education about the diagnosis of CHRPE, with a focus on the significance of regular eye examinations. They should also be informed about the possibility of transformation and reassured&#x000a0;that malignancy is exceedingly rare and unlikely in cases of solitary CHRPE.<xref ref-type="bibr" rid="article-140273.r1">[1]</xref>&#x000a0;Upon initial presentation of suspected PO-FLs, patients should undergo thorough education about the association with systemic polyposis syndromes and the increased risk of colon cancer development.</p>
        <p>Patients should be advised to undergo further evaluation by a gastroenterologist and to adhere to regular screening protocols, as almost all patients with FAP eventually develop colon cancer.<xref ref-type="bibr" rid="article-140273.r14">[14]</xref><xref ref-type="bibr" rid="article-140273.r11">[11]</xref>&#x000a0;Patients with FAP should undergo&#x000a0;sigmoidoscopy or colonoscopy every 1 to 2 years, starting from age 10 to 12.<xref ref-type="bibr" rid="article-140273.r11">[11]</xref>&#x000a0;In addition, patients should schedule colonoscopies when polyps are detected.<xref ref-type="bibr" rid="article-140273.r11">[11]</xref>&#x000a0;Although multiple CHRPEs or PO-FLs are observed in a significant number of FAP cases, management should include eye examinations, genetic testing, and colonoscopy.<xref ref-type="bibr" rid="article-140273.r7">[7]</xref><xref ref-type="bibr" rid="article-140273.r14">[14]</xref></p>
      </sec>
      <sec id="article-140273.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>In the context of CHRPE, a comprehensive approach involving various healthcare professionals is crucial to optimize patient-centered care, outcomes, patient safety, and team performance. Eye care professionals, mainly optometry and ophthalmology clinicians, are responsible for the initial identification of solitary CHRPE and GPR. However, interprofessional collaboration is essential due to the complexity of suspicious cases and potential systemic implications. This collaboration involves physicians, advanced practitioners, nurses, pharmacists, and other specialists.</p>
        <p>An interprofessional approach is essential for managing PO-FLs, given their association with severe systemic conditions. This strategy involves primary care clinicians, nurses, pharmacists, geneticists, oncologists, plastic surgeons, orthopedists, and gastroenterologists. Each healthcare team member has specific responsibilities, such as providing expertise, facilitating communication, ensuring timely referrals, and coordinating care. Effective communication channels are vital for sharing information, discussing treatment options, and addressing patient concerns. Through collaborative efforts, healthcare professionals can ensure comprehensive evaluation, accurate diagnosis, and optimal management of CHRPE, leading to improved patient outcomes, safety, and overall team performance.</p>
      </sec>
      <sec id="article-140273.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=140273&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=140273">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/eye-health/congenital-hypertrophy-of-retinal-pigment-epithelium/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=140273">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/140273/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=140273">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-140273.s16">
        <fig id="article-140273.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Congenital Hypertrophy of the Retinal Pigmented Epithelium (CHRPE). Solitary CHRPE lesions are typically flat and highly pigmented, and they present as dark gray or black areas. Contributed by K Tripathy, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IMG-20190408-WA0016" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-140273.s17">
        <fig id="article-140273.image.f2" position="float" orientation="portrait">
          <caption>
            <p>CHRPE With Lacunae. This image depicts a case of congenital hypertrophy of the retinal pigmented epithelium (CHRPE) with depigmented punched-out lacunae and a depigmented halo around the solitary lesion. These features become more prominent as the lesion matures and may eventually involve the entire lesion. Contributed by K Tripathy, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="chrpe" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-140273.s18">
        <fig id="article-140273.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Bear Track Pigmented Lesions. Grouped pigmentation of the retina (GPR) resembles animal footprints or bear tracks. While similar to solitary congenital hypertrophy of the retinal pigmented epithelium, GPR presents unilaterally with approximately 3 to 30 discreet lesions of varying sizes. These lesions are typically flat, round, or oval black spots with well-defined margins arranged in clusters. Contributed by&#x000a0;K Tripathy, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="grouped__CHRPE" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-140273.s19">
        <fig id="article-140273.image.f4" position="float" orientation="portrait">
          <caption>
            <p>CHRPE Associated With FAP. Congenital hypertrophy of the retinal pigmented epithelium (CHRPE) associated with familial adenomatous polyposis (FAP) often exhibits a "pisciform" (fish-shaped) appearance with irregular, depigmented borders. Filip em, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://commons.wikimedia.org/w/index.php?title=Special:MediaSearch&#x00026;search=Congenital+hypertrophy+of+the+retinal+pigment+epithelium&#x00026;type=image">Public Domain</ext-link>, via Wikimedia Commons</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CHRPE__Picture__xCreative__Commonsx" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-140273.s20">
        <title>References</title>
        <ref id="article-140273.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shields</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>Tumors and Related Lesions of the Pigmented Epithelium.</article-title>
            <source>Asia Pac J Ophthalmol (Phila)</source>
            <year>2017</year>
            <season>Mar-Apr</season>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>215</fpage>
            <page-range>215-223</page-range>
            <pub-id pub-id-type="pmid">28399346</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shields</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Mashayekhi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ho</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cater</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Solitary congenital hypertrophy of the retinal pigment epithelium: clinical features and frequency of enlargement in 330 patients.</article-title>
            <source>Ophthalmology</source>
            <year>2003</year>
            <month>Oct</month>
            <volume>110</volume>
            <issue>10</issue>
            <fpage>1968</fpage>
            <page-range>1968-76</page-range>
            <pub-id pub-id-type="pmid">14522773</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>AT</given-names>
              </name>
            </person-group>
            <article-title>Congenital focal abnormalities of the retina and retinal pigment epithelium.</article-title>
            <source>Eye (Lond)</source>
            <year>2020</year>
            <month>Nov</month>
            <volume>34</volume>
            <issue>11</issue>
            <fpage>1973</fpage>
            <page-range>1973-1988</page-range>
            <pub-id pub-id-type="pmid">32367006</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tiret</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Taiel-Sartral</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tiret</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Laroche</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic value of fundus examination in familial adenomatous polyposis.</article-title>
            <source>Br J Ophthalmol</source>
            <year>1997</year>
            <month>Sep</month>
            <volume>81</volume>
            <issue>9</issue>
            <fpage>755</fpage>
            <page-range>755-8</page-range>
            <pub-id pub-id-type="pmid">9422927</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shields</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Eagle</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>AD</given-names>
              </name>
            </person-group>
            <article-title>Adenocarcinoma arising from congenital hypertrophy of retinal pigment epithelium.</article-title>
            <source>Arch Ophthalmol</source>
            <year>2001</year>
            <month>Apr</month>
            <volume>119</volume>
            <issue>4</issue>
            <fpage>597</fpage>
            <page-range>597-602</page-range>
            <pub-id pub-id-type="pmid">11296028</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sreenivasan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rishi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Das</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Krishnakumar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Biswas</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Retinal Pigment Epithelium Adenoma and Adenocarcinoma: A Review.</article-title>
            <source>Ocul Oncol Pathol</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>121</fpage>
            <page-range>121-132</page-range>
            <pub-id pub-id-type="pmid">33981695</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rehan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Aye</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>In patients with a positive family history of familial adenomatous polyposis can the condition be diagnosed from the presence of congenital hypertrophy of the retinal pigment epithelium detected via an eye examination: A systematic review.</article-title>
            <source>Clin Exp Ophthalmol</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>48</volume>
            <issue>1</issue>
            <fpage>98</fpage>
            <page-range>98-116</page-range>
            <pub-id pub-id-type="pmid">31525261</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bonnet</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Conway</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE) as a Screening Marker for Familial Adenomatous Polyposis (FAP): Systematic Literature Review and Screening Recommendations.</article-title>
            <source>Clin Ophthalmol</source>
            <year>2022</year>
            <volume>16</volume>
            <fpage>765</fpage>
            <page-range>765-774</page-range>
            <pub-id pub-id-type="pmid">35321042</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Braga</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Ricardo</surname>
                <given-names>OMP</given-names>
              </name>
              <name>
                <surname>Cordeiro</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Vieira</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Nogueira</surname>
                <given-names>FB</given-names>
              </name>
            </person-group>
            <article-title>Suspect asymptomatic lesions: Congenital hypertrophy of the Retinal Pigment Epithelium (CHRPE).</article-title>
            <source>Rom J Ophthalmol</source>
            <year>2021</year>
            <season>Jul-Sep</season>
            <volume>65</volume>
            <issue>3</issue>
            <fpage>275</fpage>
            <page-range>275-278</page-range>
            <pub-id pub-id-type="pmid">35036651</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hyer</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Attard</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Vila-Miravet</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Pienar</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Auth</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Septer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hawkins</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Durno</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Latchford</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Management of Familial Adenomatous Polyposis in Children and Adolescents: Position Paper From the ESPGHAN Polyposis Working Group.</article-title>
            <source>J Pediatr Gastroenterol Nutr</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>68</volume>
            <issue>3</issue>
            <fpage>428</fpage>
            <page-range>428-441</page-range>
            <pub-id pub-id-type="pmid">30585891</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gurudu</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Koptiuch</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Agrawal</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Buxbaum</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Abbas Fehmi</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Fishman</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Khashab</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Jamil</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Jue</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Law</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Naveed</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Qumseya</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Sawhney</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Thosani</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Wani</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Samadder</surname>
                <given-names>NJ</given-names>
              </name>
            </person-group>
            <article-title>American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in familial adenomatous polyposis syndromes.</article-title>
            <source>Gastrointest Endosc</source>
            <year>2020</year>
            <month>May</month>
            <volume>91</volume>
            <issue>5</issue>
            <fpage>963</fpage>
            <page-range>963-982.e2</page-range>
            <pub-id pub-id-type="pmid">32169282</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vasen</surname>
                <given-names>HF</given-names>
              </name>
              <name>
                <surname>M&#x000f6;slein</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Alonso</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Aretz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bernstein</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Bertario</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Blanco</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>B&#x000fc;low</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Burn</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Capella</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Colas</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Engel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Frayling</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Friedl</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Hes</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Hodgson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>J&#x000e4;rvinen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Mecklin</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>M&#x000f8;ller</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Myrh&#x000f8;i</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nagengast</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Parc</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>de Leon</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Renkonen-Sinisalo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sampson</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Stormorken</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tejpar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Wijnen</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Guidelines for the clinical management of familial adenomatous polyposis (FAP).</article-title>
            <source>Gut</source>
            <year>2008</year>
            <month>May</month>
            <volume>57</volume>
            <issue>5</issue>
            <fpage>704</fpage>
            <page-range>704-13</page-range>
            <pub-id pub-id-type="pmid">18194984</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Coleman</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Barnard</surname>
                <given-names>NA</given-names>
              </name>
            </person-group>
            <article-title>Congenital hypertrophy of the retinal pigment epithelium: prevalence and ocular features in the optometric population.</article-title>
            <source>Ophthalmic Physiol Opt</source>
            <year>2007</year>
            <month>Nov</month>
            <volume>27</volume>
            <issue>6</issue>
            <fpage>547</fpage>
            <page-range>547-55</page-range>
            <pub-id pub-id-type="pmid">17956359</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Deibert</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ferris</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sanchez</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Weishaar</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>The link between colon cancer and congenital hypertrophy of the retinal pigment epithelium (CHRPE).</article-title>
            <source>Am J Ophthalmol Case Rep</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>15</volume>
            <fpage>100524</fpage>
            <pub-id pub-id-type="pmid">31384696</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Yaghy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>Pigmented Ocular Fundus Lesions Associated With Familial Adenomatous Polyposis.</article-title>
            <source>Ophthalmic Surg Lasers Imaging Retina</source>
            <year>2020</year>
            <month>Feb</month>
            <day>01</day>
            <volume>51</volume>
            <issue>2</issue>
            <fpage>124</fpage>
            <pub-id pub-id-type="pmid">32084287</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Traboulsi</surname>
                <given-names>EI</given-names>
              </name>
              <name>
                <surname>Apostolides</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Giardiello</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Krush</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Booker</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Hamilton</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Hussels</surname>
                <given-names>IE</given-names>
              </name>
            </person-group>
            <article-title>Pigmented ocular fundus lesions and APC mutations in familial adenomatous polyposis.</article-title>
            <source>Ophthalmic Genet</source>
            <year>1996</year>
            <month>Dec</month>
            <volume>17</volume>
            <issue>4</issue>
            <fpage>167</fpage>
            <page-range>167-74</page-range>
            <pub-id pub-id-type="pmid">9010867</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Valanzano</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cama</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Volpe</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Curia</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Mencucci</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Palmirotta</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Battista</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ficari</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Mariani-Costantini</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tonelli</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Congenital hypertrophy of the retinal pigment epithelium in familial adenomatous polyposis. Novel criteria of assessment and correlations with constitutional adenomatous polyposis coli gene mutations.</article-title>
            <source>Cancer</source>
            <year>1996</year>
            <month>Dec</month>
            <day>01</day>
            <volume>78</volume>
            <issue>11</issue>
            <fpage>2400</fpage>
            <page-range>2400-10</page-range>
            <pub-id pub-id-type="pmid">8941012</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tanabe</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ijiri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sasagawa</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Kamanaka</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kuroda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sato</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sarashina</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mizukami</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Makita</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Okumura</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Genomic insights into familial adenomatous polyposis: unraveling a rare case with whole APC gene deletion and intellectual disability.</article-title>
            <source>Hum Genome Var</source>
            <year>2024</year>
            <month>Mar</month>
            <day>29</day>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>13</fpage>
            <pub-id pub-id-type="pmid">38548799</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nieuwenhuis</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Vasen</surname>
                <given-names>HF</given-names>
              </name>
            </person-group>
            <article-title>Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): a review of the literature.</article-title>
            <source>Crit Rev Oncol Hematol</source>
            <year>2007</year>
            <month>Feb</month>
            <volume>61</volume>
            <issue>2</issue>
            <fpage>153</fpage>
            <page-range>153-61</page-range>
            <pub-id pub-id-type="pmid">17064931</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Caspari</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Olschwang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Friedl</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Mandl</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Boisson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>B&#x000f6;ker</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Augustin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kadmon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>M&#x000f6;slein</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Familial adenomatous polyposis: desmoid tumours and lack of ophthalmic lesions (CHRPE) associated with APC mutations beyond codon 1444.</article-title>
            <source>Hum Mol Genet</source>
            <year>1995</year>
            <month>Mar</month>
            <volume>4</volume>
            <issue>3</issue>
            <fpage>337</fpage>
            <page-range>337-40</page-range>
            <pub-id pub-id-type="pmid">7795585</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r21">
          <label>21</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Menon</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Carr</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kasi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <chapter-title>Familial Adenomatous Polyposis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>5</month>
            <day>5</day>
            <pub-id pub-id-type="pmid">30855821</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r22">
          <label>22</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Yen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Stanich</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Axell</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>SG</given-names>
              </name>
            </person-group>
            <chapter-title><italic>APC</italic>-Associated Polyposis Conditions</chapter-title>
            <person-group person-group-type="editor">
              <name>
                <surname>Adam</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mirzaa</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Pagon</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Amemiya</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <source>GeneReviews<sup>&#x000ae;</sup> [Internet]</source>
            <publisher-name>University of Washington, Seattle</publisher-name>
            <publisher-loc>Seattle (WA)</publisher-loc>
            <year>1998</year>
            <month>12</month>
            <day>18</day>
            <pub-id pub-id-type="pmid">20301519</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McKay</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>Congenital hypertrophy of the retinal pigment epithelium and familial adenomatous polyposis.</article-title>
            <source>Aust N Z J Ophthalmol</source>
            <year>1993</year>
            <month>Feb</month>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>3</fpage>
            <page-range>3-6</page-range>
            <pub-id pub-id-type="pmid">8388223</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Phillips</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Grist</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bennet</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Craig</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Muecke</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Suthers</surname>
                <given-names>GK</given-names>
              </name>
            </person-group>
            <article-title>Congenital hypertrophy of the retinal pigment epithelium (CHRPE) in familial colorectal cancer.</article-title>
            <source>Fam Cancer</source>
            <year>2006</year>
            <volume>5</volume>
            <issue>4</issue>
            <fpage>397</fpage>
            <page-range>397-404</page-range>
            <pub-id pub-id-type="pmid">16944273</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mirinezhad</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Mousavi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Baghri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sepehri</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ghavidel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ghojazadeh</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Somi</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Congenital Hypertrophy of Retinal Pigment Epithelium for Diagnosis of Familial Adenomatous Polyposis - the First FAP registry in Iran.</article-title>
            <source>Asian Pac J Cancer Prev</source>
            <year>2018</year>
            <month>Jan</month>
            <day>27</day>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>167</fpage>
            <page-range>167-169</page-range>
            <pub-id pub-id-type="pmid">29373909</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nusliha</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dalpatadu</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Amarasinghe</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Chandrasinghe</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Deen</surname>
                <given-names>KI</given-names>
              </name>
            </person-group>
            <article-title>Congenital hypertrophy of retinal pigment epithelium (CHRPE) in patients with familial adenomatous polyposis (FAP); a polyposis registry experience.</article-title>
            <source>BMC Res Notes</source>
            <year>2014</year>
            <month>Oct</month>
            <day>18</day>
            <volume>7</volume>
            <fpage>734</fpage>
            <pub-id pub-id-type="pmid">25326340</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Half</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bercovich</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rozen</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Familial adenomatous polyposis.</article-title>
            <source>Orphanet J Rare Dis</source>
            <year>2009</year>
            <month>Oct</month>
            <day>12</day>
            <volume>4</volume>
            <fpage>22</fpage>
            <pub-id pub-id-type="pmid">19822006</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lloyd</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Eagle</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Kwa</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Arbizo</surname>
                <given-names>VV</given-names>
              </name>
            </person-group>
            <article-title>Congenital hypertrophy of the retinal pigment epithelium. Electron microscopic and morphometric observations.</article-title>
            <source>Ophthalmology</source>
            <year>1990</year>
            <month>Aug</month>
            <volume>97</volume>
            <issue>8</issue>
            <fpage>1052</fpage>
            <page-range>1052-60</page-range>
            <pub-id pub-id-type="pmid">2402417</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Buettner</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Congenital hypertrophy of the retinal pigment epithelium.</article-title>
            <source>Am J Ophthalmol</source>
            <year>1975</year>
            <month>Feb</month>
            <volume>79</volume>
            <issue>2</issue>
            <fpage>177</fpage>
            <page-range>177-89</page-range>
            <pub-id pub-id-type="pmid">1115190</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parsons</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Rennie</surname>
                <given-names>IG</given-names>
              </name>
              <name>
                <surname>Rundle</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Dhingra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mudhar</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>AD</given-names>
              </name>
            </person-group>
            <article-title>Congenital hypertrophy of retinal pigment epithelium: a clinico-pathological case report.</article-title>
            <source>Br J Ophthalmol</source>
            <year>2005</year>
            <month>Jul</month>
            <volume>89</volume>
            <issue>7</issue>
            <fpage>920</fpage>
            <page-range>920-1</page-range>
            <pub-id pub-id-type="pmid">15965180</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shields</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Tso</surname>
                <given-names>MO</given-names>
              </name>
            </person-group>
            <article-title>Congenital grouped pigmentation of the retina. Histopathologic description and report of a case.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1975</year>
            <month>Nov</month>
            <volume>93</volume>
            <issue>11</issue>
            <fpage>1153</fpage>
            <pub-id pub-id-type="pmid">1191104</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Traboulsi</surname>
                <given-names>EI</given-names>
              </name>
              <name>
                <surname>Murphy</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>de la Cruz</surname>
                <given-names>ZC</given-names>
              </name>
              <name>
                <surname>Maumenee</surname>
                <given-names>IH</given-names>
              </name>
              <name>
                <surname>Green</surname>
                <given-names>WR</given-names>
              </name>
            </person-group>
            <article-title>A clinicopathologic study of the eyes in familial adenomatous polyposis with extracolonic manifestations (Gardner's syndrome).</article-title>
            <source>Am J Ophthalmol</source>
            <year>1990</year>
            <month>Nov</month>
            <day>15</day>
            <volume>110</volume>
            <issue>5</issue>
            <fpage>550</fpage>
            <page-range>550-61</page-range>
            <pub-id pub-id-type="pmid">2173407</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gun</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Akcay</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kanar</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>&#x0015e;im&#x0015f;ek</surname>
                <given-names>&#x0015e;</given-names>
              </name>
            </person-group>
            <article-title>From an asymptomatic lesion to a vision-threatening condition: Congenital hypertrophy of the retinal pigment epithelium complicated by choroidal neovascular membrane.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2020</year>
            <month>Oct</month>
            <volume>68</volume>
            <issue>10</issue>
            <fpage>2288</fpage>
            <page-range>2288-2290</page-range>
            <pub-id pub-id-type="pmid">32971696</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Augsburger</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Henson</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Hershberger</surname>
                <given-names>VS</given-names>
              </name>
              <name>
                <surname>Trichopoulos</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Topographical distribution of typical unifocal congenital hypertrophy of retinal pigment epithelium.</article-title>
            <source>Graefes Arch Clin Exp Ophthalmol</source>
            <year>2006</year>
            <month>Nov</month>
            <volume>244</volume>
            <issue>11</issue>
            <fpage>1412</fpage>
            <page-range>1412-4</page-range>
            <pub-id pub-id-type="pmid">16568286</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garoon</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Harbour</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>Congenital Hypertrophy of the Retinal Pigment Epithelium Presenting With Secondary Choroidal Neovascularization.</article-title>
            <source>Ophthalmic Surg Lasers Imaging Retina</source>
            <year>2018</year>
            <month>Apr</month>
            <day>01</day>
            <volume>49</volume>
            <issue>4</issue>
            <fpage>276</fpage>
            <page-range>276-277</page-range>
            <pub-id pub-id-type="pmid">29664987</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shields</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Eagle</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Lally</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Malignant transformation of congenital hypertrophy of the retinal pigment epithelium.</article-title>
            <source>Ophthalmology</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>116</volume>
            <issue>11</issue>
            <fpage>2213</fpage>
            <page-range>2213-6</page-range>
            <pub-id pub-id-type="pmid">19744732</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meyer</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Rodrigues</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Mennel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Kroll</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Grouped congenital hypertrophy of the retinal pigment epithelium follows developmental patterns of pigmentary mosaicism.</article-title>
            <source>Ophthalmology</source>
            <year>2005</year>
            <month>May</month>
            <volume>112</volume>
            <issue>5</issue>
            <fpage>841</fpage>
            <page-range>841-7</page-range>
            <pub-id pub-id-type="pmid">15878064</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meyer</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Freyschmidt-Paul</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Happle</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kroll</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Unilateral linear hyperpigmentation of the skin with ipsilateral sectorial hyperpigmentation of the retina.</article-title>
            <source>Am J Med Genet A</source>
            <year>2004</year>
            <month>Apr</month>
            <day>01</day>
            <volume>126A</volume>
            <issue>1</issue>
            <fpage>89</fpage>
            <page-range>89-92</page-range>
            <pub-id pub-id-type="pmid">15039978</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aiello</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Traboulsi</surname>
                <given-names>EI</given-names>
              </name>
            </person-group>
            <article-title>Pigmented fundus lesions in a preterm infant with familial adenomatous polyposis.</article-title>
            <source>Arch Ophthalmol</source>
            <year>1993</year>
            <month>Mar</month>
            <volume>111</volume>
            <issue>3</issue>
            <fpage>302</fpage>
            <page-range>302-3</page-range>
            <pub-id pub-id-type="pmid">8383485</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Traboulsi</surname>
                <given-names>EI</given-names>
              </name>
              <name>
                <surname>Krush</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Gardner</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Booker</surname>
                <given-names>SV</given-names>
              </name>
              <name>
                <surname>Offerhaus</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Yardley</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Hamilton</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Luk</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Giardiello</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Welsh</surname>
                <given-names>SB</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and importance of pigmented ocular fundus lesions in Gardner's syndrome.</article-title>
            <source>N Engl J Med</source>
            <year>1987</year>
            <month>Mar</month>
            <day>12</day>
            <volume>316</volume>
            <issue>11</issue>
            <fpage>661</fpage>
            <page-range>661-7</page-range>
            <pub-id pub-id-type="pmid">3821797</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berk</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>McLeod</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Parker</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Congenital hypertrophy of the retinal pigment epithelium as a marker for familial adenomatous polyposis.</article-title>
            <source>Dis Colon Rectum</source>
            <year>1988</year>
            <month>Apr</month>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>253</fpage>
            <page-range>253-7</page-range>
            <pub-id pub-id-type="pmid">2896112</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodrigues</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Cavallini</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Dalloul</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Jorge</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Retinal sensitivity and photoreceptor arrangement changes secondary to congenital simple hamartoma of retinal pigment epithelium.</article-title>
            <source>Int J Retina Vitreous</source>
            <year>2019</year>
            <volume>5</volume>
            <fpage>5</fpage>
            <pub-id pub-id-type="pmid">30675383</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ordu&#x000f1;a-Azcona</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gili</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>De Manuel-Triantafilo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Flores-Rodriguez</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Solitary congenital hypertrophy of the retinal pigment epithelium features by high-definition optical coherence tomography.</article-title>
            <source>Eur J Ophthalmol</source>
            <year>2014</year>
            <season>Jul-Aug</season>
            <volume>24</volume>
            <issue>4</issue>
            <fpage>566</fpage>
            <page-range>566-9</page-range>
            <pub-id pub-id-type="pmid">24366775</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Francis</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Sobol</surname>
                <given-names>EK</given-names>
              </name>
              <name>
                <surname>Greenberg</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Folberg</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Abramson</surname>
                <given-names>DH</given-names>
              </name>
            </person-group>
            <article-title>Optical Coherence Tomography Characteristics of the Choroid Underlying Congenital Hypertrophy of the Retinal Pigment Epithelium.</article-title>
            <source>Ocul Oncol Pathol</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>6</volume>
            <issue>4</issue>
            <fpage>238</fpage>
            <page-range>238-243</page-range>
            <pub-id pub-id-type="pmid">33005612</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Touri&#x000f1;o</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez-Ares</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>L&#x000f3;pez-Valladares</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>G&#x000f3;mez-Ulla</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>G&#x000f3;mez-Torreiro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Capeans</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Fluorescein angiographic features of the congenital hypertrophy of the retinal pigment epithelium in the familial adenomatous polyposis.</article-title>
            <source>Int Ophthalmol</source>
            <year>2005</year>
            <season>Feb-Apr</season>
            <volume>26</volume>
            <issue>1-2</issue>
            <fpage>59</fpage>
            <page-range>59-65</page-range>
            <pub-id pub-id-type="pmid">16779566</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>DY</given-names>
              </name>
              <name>
                <surname>Hwang</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Bird</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Tsang</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>Fundus autofluorescence and optical coherence tomography of congenital grouped albinotic spots.</article-title>
            <source>Retina</source>
            <year>2010</year>
            <month>Sep</month>
            <volume>30</volume>
            <issue>8</issue>
            <fpage>1217</fpage>
            <page-range>1217-22</page-range>
            <pub-id pub-id-type="pmid">20539258</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Almeida</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kaliki</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>CL</given-names>
              </name>
            </person-group>
            <article-title>Autofluorescence of intraocular tumours.</article-title>
            <source>Curr Opin Ophthalmol</source>
            <year>2013</year>
            <month>May</month>
            <volume>24</volume>
            <issue>3</issue>
            <fpage>222</fpage>
            <page-range>222-32</page-range>
            <pub-id pub-id-type="pmid">23429597</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shanmugam</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Konana</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Ramanjulu</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mishra</surname>
                <given-names>KCD</given-names>
              </name>
              <name>
                <surname>Sagar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Simakurthy</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Ocular coherence tomography angiography features of congenital hypertrophy of retinal pigment epithelium.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>67</volume>
            <issue>4</issue>
            <fpage>563</fpage>
            <page-range>563-566</page-range>
            <pub-id pub-id-type="pmid">30900602</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zucchiatti</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Battaglia Parodi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pala</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bandello</surname>
                <given-names>FM</given-names>
              </name>
            </person-group>
            <article-title>Macular congenital hypertrophy of the retinal pigment epithelium: a case report.</article-title>
            <source>Eur J Ophthalmol</source>
            <year>2010</year>
            <season>May-Jun</season>
            <volume>20</volume>
            <issue>3</issue>
            <fpage>621</fpage>
            <page-range>621-4</page-range>
            <pub-id pub-id-type="pmid">20155702</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mitchem</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>JF</given-names>
              </name>
            </person-group>
            <article-title>Adenomatous Polyposis Syndromes: Diagnosis and Management.</article-title>
            <source>Clin Colon Rectal Surg</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>29</volume>
            <issue>4</issue>
            <fpage>321</fpage>
            <page-range>321-329</page-range>
            <pub-id pub-id-type="pmid">31777463</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bandyopadhyay</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Basu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Vatwani</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Shekhar</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Congenital simple hamartoma of the retinal pigment epithelium with depigmentation at the margin in an Indian female.</article-title>
            <source>GMS Ophthalmol Cases</source>
            <year>2019</year>
            <volume>9</volume>
            <fpage>Doc23</fpage>
            <pub-id pub-id-type="pmid">31355121</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chawla</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Venkatesh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Shaikh</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Vohra</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Molla</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Verma</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Combined Hamartoma of the Retina and Retinal Pigment Epithelium: An Optical Coherence Tomography-Based Reappraisal.</article-title>
            <source>Am J Ophthalmol</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>181</volume>
            <fpage>88</fpage>
            <page-range>88-96</page-range>
            <pub-id pub-id-type="pmid">28669779</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kumar</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Chawla</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Omega Sign: A Distinct Optical Coherence Tomography Finding in Macular Combined Hamartoma of Retina and Retinal Pigment Epithelium.</article-title>
            <source>Ophthalmic Surg Lasers Imaging Retina</source>
            <year>2017</year>
            <month>Feb</month>
            <day>01</day>
            <volume>48</volume>
            <issue>2</issue>
            <fpage>122</fpage>
            <page-range>122-125</page-range>
            <pub-id pub-id-type="pmid">28195614</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r54">
          <label>54</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Geetha</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Chorioretinitis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">31869169</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tripathy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sarma</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mazumdar</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Commentary: Inner retinal excavation in torpedo maculopathy and proposed type 3 lesions in optical coherence tomography.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>66</volume>
            <issue>8</issue>
            <fpage>1213</fpage>
            <page-range>1213-1214</page-range>
            <pub-id pub-id-type="pmid">30038187</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Trichopoulos</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Augsburger</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Schneider</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Adenocarcinoma arising from congenital hypertrophy of the retinal pigment epithelium.</article-title>
            <source>Graefes Arch Clin Exp Ophthalmol</source>
            <year>2006</year>
            <month>Jan</month>
            <volume>244</volume>
            <issue>1</issue>
            <fpage>125</fpage>
            <page-range>125-8</page-range>
            <pub-id pub-id-type="pmid">15983818</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mehta</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Gal-Or</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Barbazetto</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Modi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Shields</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Freund</surname>
                <given-names>KB</given-names>
              </name>
            </person-group>
            <article-title>ATYPICAL CONGENITAL HYPERTROPHY OF THE RETINAL PIGMENT EPITHELIUM COMPLICATED BY PRESUMED RETINAL PIGMENT EPITHELIAL ADENOMA AND EXUDATIVE MACULOPATHY.</article-title>
            <source>Retin Cases Brief Rep</source>
            <year>2021</year>
            <month>May</month>
            <day>01</day>
            <volume>15</volume>
            <issue>3</issue>
            <fpage>330</fpage>
            <page-range>330-334</page-range>
            <pub-id pub-id-type="pmid">30063581</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140273.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moulin</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Zografos</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Schalenbourg</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>RPE adenocarcinoma arising from a congenital hypertrophy of the RPE (CHRPE) treated with proton therapy.</article-title>
            <source>Klin Monbl Augenheilkd</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>231</volume>
            <issue>4</issue>
            <fpage>411</fpage>
            <page-range>411-3</page-range>
            <pub-id pub-id-type="pmid">24771179</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
